Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
1 other identifier
observational
100
1 country
1
Brief Summary
To study the association between aristolochic acid and urothelial carcinoma in Taiwan
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 22, 2009
CompletedFirst Posted
Study publicly available on registry
March 24, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedFebruary 22, 2012
February 1, 2012
March 22, 2009
February 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the incidence of aristolochic-acid DNA adduct in the samples
one week
Study Arms (3)
Urothelial carcinoma
The DNA samples extracted from the urothelial carcinoma tissue
RCC
the DNA sample extracted from RCC
Non-cancer
The DNA sample extracted from the non-cancerous kidney tissue
Eligibility Criteria
The patients who received nephrectomies
You may qualify if:
- the resected kidney tissue in the tissue bank
You may not qualify if:
- the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Biospecimen
DNA extracted from the resected tissue samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- National Taiwan University Hospital
Study Record Dates
First Submitted
March 22, 2009
First Posted
March 24, 2009
Study Start
March 1, 2009
Study Completion
March 1, 2012
Last Updated
February 22, 2012
Record last verified: 2012-02